Human Genome Epidemiology Literature Finder
Rare Diseases
|
Records 1 - 30 (of 90 Records) |
| Query Trace: Biliary Tract Cancer[original query] |
|---|
| Effect of comprehensive cancer genomic profiling on therapeutic strategies and clinical outcomes in patients with advanced biliary tract cancer: A prospective multicenter study. Frontiers in oncology 2022 9 12 988527. Takada Kohichi, Kubo Tomohiro, Kikuchi Junko, Yoshida Makoto, Murota Ayako, Arihara Yohei, Nakamura Hajime, Nagashima Hiroyuki, Tanabe Hiroki, Sugita Shintaro, Tanaka Yumi, Miura Ayana, Ohhara Yoshihito, Ishiguro Atsushi, Yokouchi Hiroshi, Kawamoto Yasuyuki, Mizukami Yusuke, Ohnishi Hirofumi, Kinoshita Ichiro, Sakurai Akihi |
| Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 Jul . Chiang Nai-Jung, Tan Kien Thiam, Bai Li-Yuan, Hsiao Chin-Fu, Huang Chung-Yu, Hung Yi-Ping, Huang Chien-Jui, Chen San-Chi, Shan Yan-Shen, Chao Yee, Huang Yi-Hsiang, Lee I-Cheng, Lee Pei-Chang, Su Yung-Yeh, Chen Shu-Jen, Yeh Chun-Nan, Chen Li-Tzong, Chen Ming-Hua |
| Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures. JCO precision oncology 2022 6 6 e2100510. Mody Kabir, Jain Prerna, El-Refai Sherif M, Azad Nilofer S, Zabransky Daniel J, Baretti Marina, Shroff Rachna T, Kelley R Katie, El-Khouiery Anthony B, Hockenberry Adam J, Lau Denise, Lesinski Gregory B, Yarchoan Ma |
| Phase Ib study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis. Hepatology (Baltimore, Md.) 2022 May . Zhou Jun, Sun Yongkun, Zhang Wen, Yuan Jiajia, Peng Zhi, Wang Wei, Gong Jifang, Yang Lin, Cao Yanshuo, Zhao Hong, Chen Chao, Wang Weifeng, Shen Lin, Zhou Aipi |
| A rare genetic variant in the manganese transporter SLC30A10 and elevated liver enzymes in the general population. Hepatology international 2022 4 16 (3): 702-711. Seidelin Anne-Sofie, Nordestgaard Børge Grønne, Tybjærg-Hansen Anne, Yaghootkar Hanieh, Stender Stef |
| Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants. JAMA oncology 2022 4 8 (6): 871-878. Momozawa Yukihide, Sasai Rumi, Usui Yoshiaki, Shiraishi Kouya, Iwasaki Yusuke, Taniyama Yukari, Parsons Michael T, Mizukami Keijiro, Sekine Yuya, Hirata Makoto, Kamatani Yoichiro, Endo Mikiko, Inai Chihiro, Takata Sadaaki, Ito Hidemi, Kohno Takashi, Matsuda Koichi, Nakamura Seigo, Sugano Kokichi, Yoshida Teruhiko, Nakagawa Hidewaki, Matsuo Keitaro, Murakami Yoshinori, Spurdle Amanda B, Kubo Michia |
| HER2 Aberrations as a Novel Marker in Advanced Biliary Tract Cancer. Frontiers in oncology 2022 3 12 834104. Kim Hongsik, Kim Ryul, Kim Hye Ryeon, Jo Hyunji, Kim Hana, Ha Sang Yun, Park Joon Oh, Park Young Suk, Kim Seung T |
| Phase II Study of Ramucirumab in Advanced Biliary Tract Cancer Previously Treated By Gemcitabine-Based Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 3 28 (11): 2229-2236. Lee Sunyoung, Shroff Rachna T, Makawita Shalini, Xiao Lianchun, Danner De Armas Anaemy, Bhosale Priya, Reddy Kavitha, Shalaby Ahmed, Raghav Kanwal, Pant Shubham, Wolff Robert A, Javle Mili |
| Mendelian randomization study of circulating lipids and biliary tract cancer among East Asians. BMC cancer 2022 3 22 (1): 273. Wang Jun, Zhuge Jinke, Feng Dongxu, Zhang Bo, Xu Jianying, Zhao Dongkang, Fei Zhewei, Huang Xia, Shi Wenj |
| Clinical Implications of BRCA Mutations in Advanced Biliary Tract Cancer. Oncology 2022 Oct . Kim Hyera, Kim Jin Young, Park Keon |
| Hereditary cancer variants and homologous recombination deficiency in biliary tract cancer. Journal of hepatology 2022 10 78 (2): 333-342. Okawa Yuki, Iwasaki Yusuke, Johnson Todd A, Ebata Nobutaka, Inai Chihiro, Endo Mikiko, Maejima Kazuhiro, Sasagawa Shota, Fujita Masashi, Matsuda Koichi, Murakami Yoshinori, Nakamura Toru, Hirano Satoshi, Momozawa Yukihide, Nakagawa Hidewa |
| Transcriptional repression and apoptosis influence the effect of APOBEC3A/3B functional polymorphisms on biliary tract cancer risk. International journal of cancer 2022 1 150 (11): 1825-1837. Liu Wenbin, Ji Hongxiang, Zhao Jun, Song Jiahui, Zheng Shaoling, Chen Lei, Li Peng, Tan Xiaojie, Ding Yibo, Pu Rui, Yin Jianhua, Han Xue, Cao Guangw |
| Circulating Cell-Free DNA-Based Comprehensive Molecular Analysis of Biliary Tract Cancers Using Next-Generation Sequencing. Cancers 2022 1 14 (1): . Csoma Szilvia Lilla, Bedekovics Judit, Veres Gerg?, Árokszállási Anita, András Csilla, Méhes Gábor, Mokánszki Atti |
| Genomics driven precision oncology in advanced biliary tract cancer improves survival. Neoplasia (New York, N.Y.) 2023 6 42 100910. Chandan Kumar-Sinha, Pankaj Vats, Nguyen Tran, Dan R Robinson, Valerie Gunchick, Yi-Mi Wu, Xuhong Cao, Yu Ning, Rui Wang, Erica Rabban, Janice Bell, Sunita Shankar, Rahul Mannan, Yuping Zhang, Mark M Zalupski, Arul M Chinnaiyan, Vaibhav Sah |
| ARID1A Mutation from Targeted NGS Predicts Primary Resistance to Gemcitabine and Cisplatin Chemotherapy in Advanced Biliary Tract Cancer. Cancer research and treatment 2023 5 . Sung Hwan Lee, Jaekyung Cheon, Seoyoung Lee, Beodeul Kang, Chan Kim, Hyo Sup Shim, Young Nyun Park, Sanghoon Jung, Sung Hoon Choi, Hye Jin Choi, Choong-Kun Lee, Hong Jae Ch |
| Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial. Nature medicine 2023 4 . Subbiah Vivek, Kreitman Robert J, Wainberg Zev A, Gazzah Anas, Lassen Ulrik, Stein Alexander, Wen Patrick Y, Dietrich Sascha, de Jonge Maja J A, Blay Jean-Yves, Italiano Antoine, Yonemori Kan, Cho Daniel C, de Vos Filip Y F L, Moreau Philippe, Fernandez Elena Elez, Schellens Jan H M, Zielinski Christoph C, Redhu Suman, Boran Aislyn, Passos Vanessa Q, Ilankumaran Palanichamy, Bang Yung-J |
| Successful Treatment of Metastatic Gallbladder Carcinoma with a High Tumor Mutational Burden Using Pembrolizumab: A Case Report. Internal medicine (Tokyo, Japan) 2023 3 . Uehara Sanae, Naganuma Atsushi, Furuichi Nozomi, Furusawa Ai, Kaburagi Takuya, Naruse Hiroaki, Tomaru Shota, Sano Nozomi, Suzuki Yuhei, Masuda Tomoyuki, Hoshino Takashi, Yasuoka Hidetoshi, Tanaka Yuko, Saito Shuichi, Hatanaka Takeshi, Kakizaki Sato |
| Survival benefit and biomarker of PD-1 inhibitor combination therapy in first-line of advanced biliary tract cancer: A retrospective study. Cancer medicine 2023 11 . Jingyi Guo, Qun Zhou, Mingzhen Zhou, Hengheng Dai, Lin Li, Yudong Qiu, Liang Mao, Baorui Liu, Jie Sh |
| Casual effects of type 1 diabetes mellitus on site-specific digestive cancers: a Mendelian randomisation analysis. Frontiers in endocrinology 2024 9 15 1407329. Jinli Zhao, Wenjin Li, Libo Chen, Mingyong Li, Weiming De |
| Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a predictive biomarker for immune checkpoint inhibitors in biliary tract cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 8 . Yeong Hak Bang, Choong-Kun Lee, Kyunghye Bang, Hyung-Don Kim, Kyu-Pyo Kim, Jae Ho Jeong, Inkeun Park, Baek-Yeol Ryoo, Dong Ki Lee, Hye Jin Choi, Taek Chung, Seung Hyuck Jeon, Eui-Cheol Shin, Chiyoon Oum, Seulki Kim, Yoojoo Lim, Gahee Park, Chang Ho Ahn, Taebum Lee, Richard S Finn, Chan-Young Ock, Jinho Shin, Changhoon Y |
| Whole-exome sequencing reveals novel cancer genes and actionable targets in biliary tract cancers in primary sclerosing cholangitis. Hepatology communications 2024 7 8 (7): . Marit M Grimsrud, Michael Forster, Benjamin Goeppert, Georg Hemmrich-Stanisak, Irmi Sax, Krzysztof Grzyb, Peder R Braadland, Alphonse Charbel, Carmen Metzger, Thomas Albrecht, Tim Alexander Steiert, Matthias Schlesner, Michael P Manns, Arndt Vogel, Sheraz Yaqub, Tom H Karlsen, Peter Schirmacher, Kirsten M Boberg, Andre Franke, Stephanie Roessler, Trine Folsera |
| The causal relationship between cathepsins and digestive system tumors: a Mendelian randomization study. Frontiers in oncology 2024 4 14 1365138. Xupeng Huang, Houbo Deng, Bo Zhang, Kuisong Wang, Yi Qu, Ting Li, Tiejun L |
| RBM10 C761Y mutation induced oncogenic ASPM isoforms and regulated ?-catenin signaling in cholangiocarcinoma. Journal of experimental & clinical cancer research : CR 2024 4 43 (1): 104. Jiang Chang, Yaodong Zhang, Tao Zhou, Qian Qiao, Jijun Shan, Yananlan Chen, Wangjie Jiang, Yirui Wang, Shuochen Liu, Yuming Wang, Yue Yu, Changxian Li, Xiangcheng |
| DNA Checkpoint Gene Mutation as a Biomarker for Immune Checkpoint Inhibitor Therapy in Advanced Biliary Tract Cancer. Anticancer research 2024 4 44 (5): 2103-2108. Ji Eun Shin, Seung Tae K |
| The effect of metabolism-related lifestyle and clinical risk factors on digestive system cancers in East Asian populations: a two-sample Mendelian randomization analysis. Scientific reports 2024 4 14 (1): 9474. Xianlei Cai, Xueying Li, Chao Liang, Miaozun Zhang, Zhebin Dong, Weiming |
| Survival outcomes of Durvalumab in combination to cisplatin and gemcitabine in advanced biliary tract cancer: real world results from a single Italian institution. Oncology 2024 12 1-31. Margherita Rimini, Silvia Foti, Silvia Camera, Federico Rossari, Francesco Vitiello, Federica Lo Prinzi, Luca Aldrighetti, Francesco De Cobelli, Federica Pedica, Paolo Giorgio Arcidiacono, Mara Persano, Stefano Cascinu, Andrea Casadei-Gardi |
| Usefulness of multigene liquid biopsy of bile for identifying driver genes of biliary duct cancers. Cancer science 2024 10 . Shin Ito, Mika Ando, Shuichi Aoki, Satoshi Soma, Jie Zhang, Naohiro Hirano, Ryosuke Kashiwagi, Keigo Murakami, Shingo Yoshimachi, Hideaki Sato, Akiko Kusaka, Masahiro Iseki, Koetsu Inoue, Masamichi Mizuma, Kiyoshi Kume, Kei Nakagawa, Atsushi Masamune, Naoki Asano, Jun Yasuda, Michiaki Un |
| Concordance of ctDNA and tissue genomic profiling in advanced biliary tract cancer. Journal of hepatology 2024 10 . Sohyun Hwang, Seonjeong Woo, Beodeul Kang, Haeyoun Kang, Jung Sun Kim, Sung Hwan Lee, Chang Il Kwon, Dong Soo Kyung, Hwang-Phill Kim, Gwangil Kim, Chan Kim, Hong Jae Ch |
| Atezolizumab Plus Chemotherapy With or Without Bevacizumab in Advanced Biliary Tract Cancer: Clinical and Biomarker Data From the Randomized Phase II IMbrave151 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2024 10 JCO2400337. Teresa Macarulla, Zhenggang Ren, Hong Jae Chon, Joon Oh Park, Jin Won Kim, Tiziana Pressiani, Daneng Li, Lyudmila Zhukova, Andrew X Zhu, Ming-Huang Chen, Stephen P Hack, Stephanie Wu, Bo Liu, Xiangnan Guan, Shan Lu, Yulei Wang, Anthony B El-Khouei |
| A phase II study to evaluate the safety and efficacy of anlotinib combined with toripalimab for advanced biliary tract cancer. Clinical & translational immunology 2024 1 13 (1): e1483. Mingzhen Zhou, Yuncheng Jin, Sihui Zhu, Chen Xu, Lin Li, Baorui Liu, Jie Sh |
- Page last reviewed:Feb 1, 2024
- Content source: